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Cardiac resynchronization therapy (CRT) is recommended for select patients with dilated
cardiomyopathy (DCM). Here, we describe the case of a 62-year-old patient with non-
ischemic dilated cardiomyopathy, of functional class NYHA III, with left bundle branch
block (LBBB) and 90% stenosis of the great cardiac vein (GCV), which was revealed as a
result of coronary sinus venography during a CRT-P implantation procedure. A left-
ventricular electrode was introduced to the posterolateral vein. Following CRT-P implanta-
tion a partial improvement was observed. In view of the patient's remaining apical
segment contractility disorder and the coexistence of great cardiac vein stenosis, a
hypothesis was put forward that the cause of these disorders was passive hyperemia of
a portion of the left ventricle. Successful GCV angioplasty and BMS implantation was
followed by clinical and echocardiographic improvement.
Two months after the angioplasty, occlusion of the vein was detected, but repeated
percutaneous treatment was unsuccessful.
& 2013 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp.z o.o. All
rights reserved.
.Introduction
Cardiac resynchronization therapy (CRT) is a recommended
treatment option for patients with dilated cardiomyopathy
(DCM) of NYHA functional class III and IV and a left ventricular
ejection fraction ≤35%, a sinus rhythm and widened QRS for left
bundle branch block (LBBB) morphology ≥120ms and non-LBBB
morphology ≥150ms. Currently, patients in NYHA class II may
be considered for this procedure—if their left ventricularch Society of Cardiology.
et, 44-100 Gliwice, Polan
G. Kubiak).ejection fraction is ≤30% and LBBB morphology QRS duration
is ≥130ms or non-LBBB morphology QRS is ≥150ms [1].
Here, we describe the case of a 62-year-old patient with a
non-ischemic dilated cardiomyopathy, of NYHA functional
class III and LBBB morphology (QRS 140 ms). Echocardio-
graphic examination revealed a signiﬁcant dysfunction of
the left ventricle (LV), the estimated left ventricular ejection
fraction (LVEF) was 20%. Additionally, markers of mechanical
asynchrony were abnormal: the intraventricular delay [IVD]Published by Elsevier Urban & Partner Sp.z o.o. All rights reserved.
d. Tel.: +48 602 538 237.
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c o r e t v a s a 5 5 ( 2 0 1 3 ) e 5 4 1 – e 5 4 4e542was 90 ms, and the intraventricular asynchrony, assessed as
septal to posterior wall motion delay [SPWMD], was 200 ms.
The patient subsequently qualiﬁed for cardiac resynchro-
nization therapy. The coronary sinus was intubated with a 9F
catheter in the typical way, and a venography was performed.
These results disclosed a critical (490%) stenosis of the great
cardiac vein (GCV), a slightly visible proximal segment of the
vessel and a large posterior lateral vein (VPL) (Fig. 1).
Moreover, an additional connection between the proximal
segment of the GCV and the right atrium was found. A left-
ventricular lead (Attain OTW—Medtronic) was introduced to
the VPL, and the optimal location for its tip was obtained on
the LV side wall. The tip of right-ventricular lead (CapsureFix
Novus—Medtronic) was placed in the ventricular outﬂow
tract, and the atrial lead (Capsure Novus—Medtronic) was
placed in the right cardiac auricle (Fig. 2).
The biventricular pacemaker (Insinc III DR—Medtronic)
was implanted in the left subclavian area. Following CRT-P
implantation, improvements in quality of life, functional
status, and exercise capacity, as well as classiﬁcation inFig. 1 – Severe stenosis of great cardiac vein.
Fig. 2 – Balloon predilatation of stenosis.NYHA functional class II were observed. Despite improved
synchrony and global contractility of the left ventricle (LVEF
31%, Table 1), echocardiography revealed remaining apical
segment contractility disorders. The hypothesis that this
abnormality and the coexistence of GCV stenosis were a
consequence of segmental left vertical muscle passive hyper-
emia was put forward.
Two months after CRT-P implantation, from a right inter-
nal jugular vein access, a GCV angioplasty was performed.
Following a CS venography, 5000 UHF units were adminis-
tered, a Whisper LS (Guidant) guide wire was passed through
the stenosis, and pre-dilatation with a 3.020 mm2 balloon
(Sprinter—Medtronic) was performed (Fig. 2). Then, a
4.023 mm2 cobalt-chrome stent (Genius-Magic, EUROCOR)
was implanted and pressurized in the proximal portion with
a force of 16 atm (the ﬁnal diameter was 4.32 mm). Complete
widening of the GCV was obtained (Fig. 3).
Dual antiplatelet therapy with acetylosalicylic acid (75 mg/
day) and clopidogrel (75 mg/day) was subsequently intro-
duced, as this is the standard of care for patients undergoing
elective PCI. Additionally, the patient received acenocou-
marol in doses to achieve INR values between two and three
for one month after the venoplasty. Following the GCV
angioplasty, a further increase in the LVEF, a decrease in
the left ventricular end-diastolic volume (LVEDV), a drop in
the NT-proBNP concentration and an increase in the 6-min
walking distance were observed.
Two months after the procedure, an angioCT of the heart
was performed, which demonstrated vein occlusion inside of
the previously implanted stent. A selective venography con-
ﬁrmed this result, although distal passing of a guide wire
through the occluded area of the vessel was impossible and
resulted in the cessation of further therapy (Fig. 4).
In subsequent months, a drop in the LVEF by 6.3 percen-
tage points to the value of 35% was observed, as well as an
increase in the NT-proBNP concentration to the value of
1686.78 pg/ml. The values for the LVEF, LVEDV, NT-proBNP
concentration, and distance covered in the 6-MWT and
functional class according to the NYHA at respective treat-
ment stages are presented in Table 1.
Angioplasties within the venous system are performed
relatively seldom, in contrast to percutaneous arterial angio-
plasty. PTVA is performed most frequently in dialyzed
patients. Stenoses of the vein that collects blood from the
arteriovenous ﬁstula [2], as well as of the superior caval vein,
as a complication in percutaneous dialysis from an internal
jugular venopuncture access [3] are broadened.
Cases of required implantation of the left-ventricular lead
from an access via the cardiac venous system showed that
approximately 10% of patients have stenoses in the cardiac
vein. PVTA of the cardiac vein is a method that facilitates
both the introduction of a left-ventricular electrode [4–9] and
its stabilization by means of vascular stenting [10].
In the medical databases, we were unable to ﬁnd a
description of a case of left ventricle dysfunction due to
cardiac vein stenosis or a description of therapeutic PTVA
of the cardiac vein. PTVA operations performed for the
purpose of left-ventricular electrode implantation, as
described in the literature, mainly concern the peripheral
venous vessel. In our institute's case records we identiﬁed
Table 1 – Echocardiographic, neurohormonal and function parameters.
Before CRT Two months after CRT One month after PTVA Follow-up
LVEF (%) 20 31 41 35
LVEDV (ml) 170.3 140.5 117.8 115
NT-proBNP (pg/ml) 2169.9 1004.1 788.9 1686.78
6-MWT (m) 450 486 527 413
NYHA III II II II
CRT—cardiac resynchronization therapy, PTVA—percutaneous venous angioplasty, LVEF—left ventricle ejection fraction, LVEDV—left
ventricle end-diastolic volume, NT-proBNP—N-terminal pro-brain natriuretic peptide, 6-MWT—six-min walking test distance.
Fig. 3 – Great cardiac vein after angioplasty and stent
implantation.
Fig. 4 – Venography 2 months later—in stent occlusion of
great cardiac vein.
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vein had to be dilated to introduce a left-ventricular lead-in
another two patients, the electrode was stabilized by stent
implantation.In the presented case, a critical stenosis of the great cardiac
vein was found during the course of a CRT-P implantation, as it
blocked the blood outﬂow from a signiﬁcant area of the left
ventricle. This ﬁnding was accompanied by segmental contrac-
tility corresponding anatomically to the blood outﬂow. The
application of resynchronization therapy lead to a signiﬁcant
improvement in the patient's condition, and after PTVA, we
observed a further improvement in echocardiographic, func-
tional and neurohormonal parameters, which later proved to
be transitional (Table 1).
Two months after PTVA, an occlusion in the stent was
found, and an attempt to restore patency turned out to be
ineffective. A previous report by Zamboni et al., who per-
formed PTVA of the internal jugular veins and the azygos
vein in patients with multiple sclerosis, demonstrated sig-
niﬁcant susceptibility of the internal jugular veins the rest-
enosis process. In a medium period of 18 months, these
authors demonstrated a lack of patency in 47% of cases;
furthermore, for the azygos vein, 96% of broadened veins
remained patent in the same time period [11].
The further transitional improvement in cardiac efﬁciency
after PTVA that was observed in the present case may
constitute an argument for passive hyperemia of the myo-
cardium as a potential factor impairing left ventricular func-
tion. However, one cannot rule out progressing improvement
in the function of the left ventricle during the course of the
resynchronizing therapy.Disclosure statement
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